|
GOLGA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.81110004560514E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64869999985662E-07 |
| Normal-vs-Stage2 |
9.599000E-03 |
| Normal-vs-Stage3 |
3.85300000005362E-06 |
| Normal-vs-Stage4 |
2.31879999978979E-07 |
| Stage1-vs-Stage2 |
2.956600E-01 |
| Stage1-vs-Stage3 |
6.713600E-01 |
| Stage1-vs-Stage4 |
8.077900E-02 |
| Stage2-vs-Stage3 |
2.477800E-01 |
| Stage2-vs-Stage4 |
4.009600E-02 |
| Stage3-vs-Stage4 |
2.648200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94279999865543E-08 |
| Normal-vs-AfricanAmerican |
1.153740E-04 |
| Normal-vs-Asian |
1.529570E-02 |
| Caucasian-vs-AfricanAmerican |
9.028800E-01 |
| Caucasian-vs-Asian |
1.632150E-02 |
| AfricanAmerican-vs-Asian |
9.321800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.02560000012775E-07 |
| Normal-vs-Female |
2.54870013982611E-10 |
| Male-vs-Female |
1.754210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.485900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.81370004862458E-09 |
| Normal-vs-Age(61-80Yrs) |
1.38360000012661E-07 |
| Normal-vs-Age(81-100Yrs) |
2.598800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.257200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.142800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.529600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.228400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.532000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.082550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.002890E-04 |
| Normal-vs-Grade 2 |
6.27569999966937E-07 |
| Normal-vs-Grade 3 |
3.63329999997219E-06 |
| Normal-vs-Grade 4 |
9.43489997240476E-09 |
| Grade 1-vs-Grade 2 |
1.049210E-01 |
| Grade 1-vs-Grade 3 |
6.341900E-02 |
| Grade 1-vs-Grade 4 |
5.660400E-01 |
| Grade 2-vs-Grade 3 |
6.602600E-01 |
| Grade 2-vs-Grade 4 |
6.781800E-03 |
| Grade 3-vs-Grade 4 |
2.179400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.15150000000475E-05 |
| Normal-vs-ccB subtype |
4.20269996581624E-09 |
| ccA subtype-vs-ccB subtype |
8.977700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97820000047422E-07 |
| Normal-vs-N1 |
4.096900E-03 |
| N0-vs-N1 |
9.702000E-02 |
|
|
